The Effect of Salmeterol on Markers of Airway Inflammation Following Segmental Allergen Challenge

2001 ◽  
Vol 163 (4) ◽  
pp. 881-886 ◽  
Author(s):  
WILLIAM J. CALHOUN ◽  
KIMBERLEY L. HINTON ◽  
JENNIFER J. KRATZENBERG
Thorax ◽  
2015 ◽  
Vol 71 (1) ◽  
pp. 35-44 ◽  
Author(s):  
Chris Carlsten ◽  
Anders Blomberg ◽  
Mandy Pui ◽  
Thomas Sandstrom ◽  
Sze Wing Wong ◽  
...  

RationaleTraffic-related air pollution has been shown to augment allergy and airway disease. However, the enhancement of allergenic effects by diesel exhaust in particular is unproven in vivo in the human lung, and underlying details of this apparent synergy are poorly understood.ObjectiveTo test the hypothesis that a 2 h inhalation of diesel exhaust augments lower airway inflammation and immune cell activation following segmental allergen challenge in atopic subjects.Methods18 blinded atopic volunteers were exposed to filtered air or 300 µg PM2.5/m3 of diesel exhaust in random fashion. 1 h post-exposure, diluent-controlled segmental allergen challenge was performed; 2 days later, samples from the challenged segments were obtained by bronchoscopic lavage. Samples were analysed for markers and modifiers of allergic inflammation (eosinophils, Th2 cytokines) and adaptive immune cell activation. Mixed effects models with ordinal contrasts compared effects of single and combined exposures on these end points.ResultsDiesel exhaust augmented the allergen-induced increase in airway eosinophils, interleukin 5 (IL-5) and eosinophil cationic protein (ECP) and the GSTT1 null genotype was significantly associated with the augmented IL-5 response. Diesel exhaust alone also augmented markers of non-allergic inflammation and monocyte chemotactic protein (MCP)-1 and suppressed activity of macrophages and myeloid dendritic cells.ConclusionInhalation of diesel exhaust at environmentally relevant concentrations augments allergen-induced allergic inflammation in the lower airways of atopic individuals and the GSTT1 genotype enhances this response. Allergic individuals are a susceptible population to the deleterious airway effects of diesel exhaust.Trial registration numberNCT01792232.


Radiology ◽  
2015 ◽  
Vol 274 (1) ◽  
pp. 267-275 ◽  
Author(s):  
Julius Renne ◽  
Jan Hinrichs ◽  
Christian Schönfeld ◽  
Marcel Gutberlet ◽  
Carla Winkler ◽  
...  

1999 ◽  
Vol 104 (6) ◽  
pp. 1174-1182 ◽  
Author(s):  
Mary Jane Thomassen ◽  
Baisakhi Raychaudhuri ◽  
Raed A. Dweik ◽  
Carol Farver ◽  
Lisa Buhrow ◽  
...  

Nitric Oxide ◽  
2005 ◽  
Vol 13 (2) ◽  
pp. 125-133 ◽  
Author(s):  
Veit J. Erpenbeck ◽  
Rudolf A. Jörres ◽  
Marc Discher ◽  
Harald Krentel ◽  
Dimitrios Tsikas ◽  
...  

2009 ◽  
Vol 107 (1) ◽  
pp. 295-301 ◽  
Author(s):  
Tanveer Ahmad ◽  
Ulaganathan Mabalirajan ◽  
Duraisamy Arul Joseph ◽  
Lokesh Makhija ◽  
Vijay Pal Singh ◽  
...  

Allergic airway inflammation (AI) is commonly associated with enhanced exhaled nitric oxide (ENO) in both humans and mice. Since mouse models are being used to understand various mechanisms of asthma, a noninvasive, simple, and reproducible method to determine ENO in mice is required for serial nonterminal assessment that can be used independent of environmental situations in which the ambient air contains substantial amounts of NO as a contaminant. The aim of this study was to noninvasively measure ENO in individual mice and to test its utility as a marker of AI in different models of allergic AI. We modified the existing ENO measuring methods by incorporating flushing and washout steps that allowed simple but reliable measurements under highly variable ambient NO conditions (1–100 ppb). This method was used to serially follow ENO in acute and chronic models of allergic AI in mice. ENO was reproducibly measured by this modified method and was positively correlated to AI in both acute and chronic models of asthma but was not independently related to airway remodeling. Resolution of AI and other related parameters in dexamethasone-treated mice resulted in reduction of ENO, further confirming this association. Restriction of allergen challenge to pulmonary but not nasal airways was associated with a smaller increase in ENO compared with allergen challenge to both. Hence, ENO can now be reliably measured in mice independent of ambient NO levels and is a valid biomarker for AI. However, nasal and pulmonary airways are likely to be independent sources of ENO, and any results must be interpreted as such.


2004 ◽  
Vol 23 (6) ◽  
pp. 876-884 ◽  
Author(s):  
C. Pilette ◽  
J.N. Francis ◽  
S.J. Till ◽  
S.R. Durham

2000 ◽  
Vol 7 (2) ◽  
pp. 182-187 ◽  
Author(s):  
Donald W Cockcroft

BACKGROUND:The present paper revisits the 1977 paper by DW Cockcroft, RE Ruffin, the late J Dolovich and FE Hargreave entitled "Allergen-induced increase in nonallergic bronchial reactivity" (Clin Allergy1977;7:503-13) that became a citation classic. Although clinical types of asthma were recognized at the time, there was a poor understanding regarding the role of allergic reactions in causing increases in airway hyperresponsiveness. The objective was to study formally Dr Altounyan's observation that patients with asthma showed increases in airway responsiveness at the times of natural allergen exposure during pollen season. Thirteen atopic patients with asthma were studied over two days, following inhalation of diluent (control) and following doubling amounts of an allergen solution at 10-min intervals until forced expiration volume in 1 s fell by 20%. Methacholine and histamine challenges were performed before, at 8 h, at 32 h and seven days following the inhalations. A significant reduction (reduction of at least one doubling concentration) in the provocative concentration that causes a 20% fall in forced expiration volume in 1 s occurred in seven of 13 patients, and more often in subjects with a late bronchoconstrictor response to allergen challenge.IMPORTANCE:The study showed that large changes in airway responsiveness could occur in patients with asthma and suggested that allergens could cause, rather than trigger, asthma. The study also led to the concept of asthma inducers and inciters -- inducers causing airway inflammation and inciters provoking bronchospasm. The results led to a series of observations that have now implicated immunoglobulin E-mediated airway inflammation as perhaps the most important cause of airway hyperresponsiveness in asthma.


Allergy ◽  
2006 ◽  
Vol 61 (5) ◽  
pp. 598-604 ◽  
Author(s):  
V. J. Erpenbeck ◽  
R. Schmidt ◽  
A. Gunther ◽  
N. Krug ◽  
J. M. Hohlfeld

Sign in / Sign up

Export Citation Format

Share Document